A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of Y-90 resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study

Mahvash, A; Chartier, S; Turco, M; Habib, P; Griffith, S; Brown, S; Kappadath, SC

Mahvash, A (通讯作者),Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Unit 1471,1515 Holcombe Blvd, Houston, TX 77030 USA.;Kappadath, SC (通讯作者),Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, 1155 Pressler St,Unit 1352, Houston, TX 77030 USA.

BMC GASTROENTEROLOGY, 2022; 22 (1):

Abstract

Background: Selective internal radiation therapy (SIRT) with yttrium-90 (Y-90) resin microspheres is an established locoregional treatment option for ......

Full Text Link